Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Search alternatives:
- Subject ("SGLT2 INHIBITORS") »
Loading…
Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes
Ferrannini, Ele, Baldi, Simona, Frascerra, Silvia, Astiarraga, Brenno, Heise, Tim, Bizzotto, Roberto, Mari, Andrea, Pieber, Thomas R., Muscelli, Elza
Published in Diabetes (New York, N.Y.) (01.05.2016)
Published in Diabetes (New York, N.Y.) (01.05.2016)
Get full text
Journal Article
Loading…
Analysis of time-dependent alterations of parameters related to erythrocytes after ipragliflozin initiation
Yamada, Tomoko, Sakaguchi, Kazuhiko, Okada, Yuko, Miura, Hiroshi, Otowa-Suematsu, Natsu, So, Anna, Komada, Hisako, Hirota, Yushi, Ohara, Takeshi, Kuroki, Yasuo, Hara, Kenta, Matsuda, Tomokazu, Kishi, Minoru, Takeda, Akihiko, Yokota, Kazuki, Tamori, Yoshikazu, Ogawa, Wataru
Published in Diabetology International (01.04.2021)
Published in Diabetology International (01.04.2021)
Get full text
Journal Article
Loading…
140-LB: Effect of Vaginal Estrogen as Hormone Replacement Therapy for Menopause on SGLT2 Inhibitor–Associated Urinary Tract Infection: A Prospective Cohort Study
GAUTAM, ASHISH, AGRAWAL, PRABHAT K., PURSNANI, NIKHIL, RANI, RUCHI
Published in Diabetes (New York, N.Y.) (01.06.2020)
Published in Diabetes (New York, N.Y.) (01.06.2020)
Get full text
Journal Article
Loading…
Loading…
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
Yale, J.-F., Bakris, G., Cariou, B., Yue, D., David-Neto, E., Xi, L., Figueroa, K., Wajs, E., Usiskin, K., Meininger, G.
Published in Diabetes, obesity & metabolism (01.05.2013)
Published in Diabetes, obesity & metabolism (01.05.2013)
Get full text
Journal Article
Loading…
Evaluating the overall renal outcomes of sodium-glucose cotransporter-2
Cao, Min-Jia, Liang, Ting-Ting, Xu, Li, Shi, Fang-Hong
Published in Diabetology and metabolic syndrome (06.01.2025)
Published in Diabetology and metabolic syndrome (06.01.2025)
Get full text
Journal Article
Loading…
Multicenter, Open-Label, 2-Arm, Pilot Trial for Safe Reduction of Basal Insulin Dose Combined with SGLT2 Inhibitor in Type 1 Diabetes Mellitus: Study Protocol for a RISING-STAR Trial
Hamaguchi, Masahide, Hashimoto, Yoshitaka, Tanaka, Toru, Hasegawa, Goji, Ishii, Michiyo, Okada, Hiroshi, Mitsuhashi, Kazuteru, Kitagawa, Noriyuki, Ushigome, Emi, Yamazaki, Masahiro, Fukui, Michiaki
Published in Clinical medicine insights. Endocrinology and diabetes (2021)
Published in Clinical medicine insights. Endocrinology and diabetes (2021)
Get full text
Journal Article
Loading…
Effect of Gemfibrozil, Rifampicin, or Probenecid on the Pharmacokinetics of the SGLT2 Inhibitor Empagliflozin in Healthy Volunteers
Macha, Sreeraj, Koenen, Rüdiger, Sennewald, Regina, Schöne, Katja, Hummel, Noemi, Riedmaier, Stephan, Woerle, Hans J., Salsali, Afshin, Broedl, Uli C.
Published in Clinical therapeutics (01.02.2014)
Published in Clinical therapeutics (01.02.2014)
Get full text
Journal Article
Loading…
Dose‐dependent glucosuria of DWP16001, a novel selective sodium–glucose cotransporter‐2 inhibitor, in healthy subjects
Hwang, Jun Gi, Lee, SeungHwan, Huh, Wan, Han, Jumi, Oh, Jaeseong, Jang, In‐Jin, Yu, Kyung‐Sang
Published in British journal of clinical pharmacology (01.09.2022)
Published in British journal of clinical pharmacology (01.09.2022)
Get full text
Journal Article
Loading…
Biotransformation and mass balance of the SGLT2 inhibitor empagliflozin in healthy volunteers
Chen, Lin-Zhi, Jungnik, Arvid, Mao, Yanping, Philip, Elsy, Sharp, Dale, Unseld, Anna, Seman, Leo, Woerle, Hans-Jürgen, Macha, Sreeraj
Published in Xenobiotica (01.06.2015)
Published in Xenobiotica (01.06.2015)
Get full text
Journal Article
Loading…
Changes in the estimated glomerular filtration rate and predictors of the renal prognosis in Japanese patients with type 2 diabetes: A retrospective study during the 12 months after the initiation of tofogliflozin
Ito, Hiroyuki, Inoue, Hideyuki, Izutsu, Takuma, Matsumoto, Suzuko, Antoku, Shinichi, Yamasaki, Tomoko, Mori, Toshiko, Togane, Michiko
Published in PloS one (21.09.2023)
Published in PloS one (21.09.2023)
Get full text
Journal Article
Loading…
Rationale, Design, and Methods of the Study of Comparison of Canagliflozin vs. Teneligliptin Against Basic Metabolic Risks in Patients with Type 2 Diabetes Mellitus (CANTABILE study): Protocol for a Randomized, Parallel-Group Comparison Trial
Son, Cheol, Kasahara, Masato, Tanaka, Tomohiro, Satoh-Asahara, Noriko, Kusakabe, Toru, Nishimura, Kunihiro, Miyamoto, Yoshihiro, Kasama, Shu, Hosoda, Kiminori
Published in Diabetes therapy (01.01.2020)
Published in Diabetes therapy (01.01.2020)
Get full text
Journal Article
Loading…
The sodium‐glucose co‐transporter 2 inhibitor tofogliflozin suppresses atherosclerosis through glucose lowering in ApoE‐deficient mice with streptozotocin‐induced diabetes
Iwamoto, Masahiko, Kubota, Tetsuya, Sakurai, Yoshitaka, Wada, Nobuhiro, Shioda, Seiji, Yamauchi, Toshimasa, Kadowaki, Takashi, Kubota, Naoto
Published in Pharmacology research & perspectives (01.08.2022)
Published in Pharmacology research & perspectives (01.08.2022)
Get full text
Journal Article
Loading…
Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study
Lee, Seung-Hwan, Min, Kyung-Wan, Lee, Byung-Wan, Jeong, In-Kyung, Yoo, Soon-Jib, Kwon, Hyuk-Sang, Choi, Yoon-Hee, Yoon, Kun-Ho
Published in Diabetes & metabolism journal (01.05.2021)
Published in Diabetes & metabolism journal (01.05.2021)
Get full text
Journal Article
Loading…
Luseogliflozin, an SGLT2 Inhibitor, in Japanese Patients With Mild/Moderate Hepatic Impairment: A Pharmacokinetic Study
Samukawa, Yoshishige, Sata, Michio, Furihata, Kenichi, Ito, Toshifumi, Ueda, Naohiko, Ochiai, Hidekazu, Sakai, Soichi, Kumagai, Yuji
Published in Clinical pharmacology in drug development (01.09.2017)
Published in Clinical pharmacology in drug development (01.09.2017)
Get full text
Journal Article
Loading…
Plasma Potassium Negatively Correlates With Sodium Chloride Cotransporter Abundance and Phosphorylation in Urinary Extracellular Vesicles From Patients With Chronic Kidney Disease
Wu, Aihua, Wolley, Martin J., Vesey, David, Terker, Andrew S., Welling, Paul A., Fenton, Robert A., Stowasser, Michael
Published in Nephrology (Carlton, Vic.) (01.03.2025)
Published in Nephrology (Carlton, Vic.) (01.03.2025)
Get full text
Journal Article
Loading…
EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA(1c) levels in db/db mice and prolongs the survival of stroke-prone rats
Zhang, Wenbin, Welihinda, Ajith, Mechanic, Jordan, Ding, Haifeng, Zhu, Liangcheng, Lu, Yuan, Deng, Zhongping, Sheng, Zelin, Lv, Binhua, Chen, Yuanwei, Roberge, Jacques Y, Seed, Brian, Wang, Yong-Xiang
Published in Pharmacological research (01.04.2011)
Published in Pharmacological research (01.04.2011)
Get full text
Journal Article
Loading…
Different renoprotective effects of luseogliflozin depend on the renal function at the baseline in patients with type 2 diabetes: A retrospective study during 12 months before and after initiation
Ito, Hiroyuki, Matsumoto, Suzuko, Izutsu, Takuma, Kusano, Eiji, Kondo, Jiro, Inoue, Hideyuki, Antoku, Shinichi, Yamasaki, Tomoko, Mori, Toshiko, Togane, Michiko
Published in PloS one (15.03.2021)
Published in PloS one (15.03.2021)
Get full text
Journal Article
Loading…
Loading…
Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes and Stage 3 Nephropathy
Yamout, Hala, Perkovic, Vlado, Davies, Melanie, Woo, Vincent, de Zeeuw, Dick, Mayer, Cristiana, Vijapurkar, Ujjwala, Kline, Irina, Usiskin, Keith, Meininger, Gary, Bakris, George
Published in American journal of nephrology (01.01.2014)
Published in American journal of nephrology (01.01.2014)
Get full text
Journal Article